evidencegaps
Primary study · included by 1 review

Neoadjuvant camrelizumab plus chemotherapy in treating locally advanced esophageal squamous cell carcinoma patients: a pilot study.

Yang 2021 · Yang Peng, Zhou Xiao, Yang Xuefeng, et al. · World journal of surgical oncology · 2021

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.
Non-Cochrane · intervention · 2026 · cited as Yang 2021 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.